📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events? (2020)

First Author: Pericleous C

Attributed to: MICA: Development of PEGylated Domain I of beta-2-glycoprotein I as a new therapeutic agent for the antiphospholipid syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kez239

PubMed Identifier: 31257438

Publication URI: http://europepmc.org/abstract/MED/31257438

Type: Journal Article/Review

Volume: 59

Parent Publication: Rheumatology (Oxford, England)

Issue: 1

ISSN: 1462-0324